أعرض في EDS

O4‐04‐01: Characterization of a humanized amyloid beta oligomer monoclonal antibody (5E3) under preclinical development for passive immunotherapy of Alzheimer's disease

التفاصيل البيبلوغرافية
العنوان: O4‐04‐01: Characterization of a humanized amyloid beta oligomer monoclonal antibody (5E3) under preclinical development for passive immunotherapy of Alzheimer's disease
المؤلفون: Brian Dupas, Neil R. Cashman, Shantha Kodihalli, Melanie Leonhardt, Bryce Hrehorak, Peter Cheung, Andrew L. Goertzen, Judith M. Silverman, Darrell Johnstone, Ross Reid, Harmoni Hoffman, Laura Saward, John Merluza, Ebrima Gibbs, Michael F. Jackson, Xiaobing Han, Cory Nykiforuk
المصدر: Alzheimer's & Dementia. 11
بيانات النشر: Wiley, 2015.
سنة النشر: 2015
مصطلحات موضوعية: Epidemiology, business.industry, medicine.drug_class, Health Policy, Passive Immunotherapy, Disease, Monoclonal antibody, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Cancer research, Medicine, Neurology (clinical), Amyloid beta oligomer, Geriatrics and Gerontology, business
تدمد: 1552-5279
1552-5260
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::922230c000f6b0c6d04282e4e6ff2cb3Test
https://doi.org/10.1016/j.jalz.2015.07.363Test
حقوق: CLOSED
رقم الانضمام: edsair.doi...........922230c000f6b0c6d04282e4e6ff2cb3
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15525279
15525260